Chinese Sinovac 83.5% Efficient: Turkish University



China’s Sinovac vaccine is 83.5% effective against the coronavirus, an Ankara-based university said on Wednesday after concluding the final phase of their clinical trials.

Hacettepe University said trials showed the vaccine would prevent hospitalization by 100%.

“One group of volunteers received the actual vaccine, while the other received a placebo,” the university said in a statement explaining the research methodology.

Neither the volunteers nor the researchers knew which jab was being given to whom, he added.

The volunteers were aged 18 to 59, with the median age being 45.

“At least one dose of actual vaccine or placebo was administered to 10,216 people […] Of these volunteers, 6,648 were included in the vaccinated group, while 3,568 were included in the placebo group. “

No deaths have occurred during the trials, the university said. However, the most common side effects were fatigue with 9.8%, headache 7.6%, muscle pain 3.8%, fever 2.5%, chills 2.4%, and pain. at the level of the injection zone 1.6%.

The university said 57.8% of the volunteers were men, while 42.24% were women.

On January 14, Turkey launched a mass vaccination campaign against COVID, starting with healthcare workers and senior officials to encourage public confidence in vaccines.

According to official figures from the Ministry of Health, Turkey has so far administered more than 9.36 million coronavirus vaccines across the country.

More than 7.26 million people to date have received their first doses of the vaccine, while more than 2.1 million have received the second dose.

* Contributions and writing by Sena Guler

The Anadolu Agency website contains only a portion of the stories offered to subscribers in the AA News Distribution System (HAS), and in summary form. Please contact us for subscription options.


Leave A Reply